Xtant Medical Holdings
XTNT
28 hedge funds and large institutions have $45.3M invested in Xtant Medical Holdings in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 5 closing their positions.
6% more capital invested
Capital invested by funds: $42.8M → $45.3M (+$2.44M)
0.29% less ownership
Funds ownership: 69.56% → 69.27% (-0.29%)
7% less funds holding
Funds holding: 30 → 28 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$53K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$49.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.7K |
| 4 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$6.65K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$13 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$85.5K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$52.6K |
| 3 |
Renaissance Technologies
New York
|
-$45.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$40.8K |
| 5 |
AE
AMH Equity
Great Neck,
New York
|
-$34.2K |
XTNT Hedge Fund Activity: Q1 2025 in Review
28 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q1 2025, worth a combined $45.3M — up 5.7% from $42.8M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of XTNT and 3 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, adding an estimated $53K. The largest seller was Altium Capital Management, cutting an estimated $85.5K.
- 28 institutional investors held Xtant Medical Holdings (XTNT) as of Q1 2025, down from 30 in Q4 2024.
- Funds reported $45.3M of Xtant Medical Holdings stock for Q1 2025, up 5.7% quarter-over-quarter.
- 3 funds opened new Xtant Medical Holdings positions in Q1 2025 and 5 closed out, a net change of -2 holders.
- The largest Xtant Medical Holdings buyer in Q1 2025 was Vanguard Group, an estimated $53K added.
- The largest Xtant Medical Holdings seller in Q1 2025 was Altium Capital Management, an estimated $85.5K sold.
Based on aggregated 13F filings for Q1 2025.